RetinAI Medical AG (RetinAI) develops software solutions to accelerate and support clinical and pharmaceutical research, clinical workflows and biomarker based decision support.

RetinAI Discovery is a platform to collect and analyze health data from the eyes, empowering communities of healthcare professionals and pharma companies with data analysis supported by computer vision, signal processing & AI.
Accelerating clinics, research and pharmaceutical workflows

Get in know Retinai

  • Headquartered in: Bern, Switzerland

  • Founded in: 2016

  • Sector: Artificial Intelligence, Cloud Computing, Health Care, Health Diagnostics, Information Technology, Machine Learning, Software

  • Investor: Industrial Tech Fund

Retinai’s vision is to support the transition from reactive to precision & patient-specific medicine for high-impact diseases in ophthalmology & neurology.

They integrate their solutions inside your server infrastructure and into medical devices, interconnecting the whole clinical pipeline and reducing the time and cost it takes to do clinical & research work, enabling their users to optimise their efforts and to do more with less.

Press enter or esc to cancel